US FDA seeks to replace Helsinki declaration with GCP standard for foreign device trials
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is inviting feedback from stakeholders on its proposal to establish uniform standards for accepting data from medical device clinical trials irrespective of whether they are conducted within or outside the country1.